Abstract:OBJECTIVE:Acute monocytic leukemia (AML)-M5 is the common type of acute myeloid leukemias in children. Studies have shown that there are abundant lipopolysaccharide (LPS) receptor (designated as CD14) molecules on the cell membrane of M5 cells and they play an important role in the diagnosis of M5, since they can be recognized and bound by mouse-anti-human CD14 monoclonal antibody (McAb). However, mouse-originated antibodies are largely not suitable for clinical application due to the severe side effects, thus "humanized antibody" is desired. As the first step for developing humanized antibody, the construction and expression of single chain antibody (scFv) with functional protein are necessary. The present study aimed to express ZCH-7-2F9 ScFv (scFv(2F9)) in eukaryotic cells and obtain the scFv(2F9) protein with a high biological activity.METHODS:Four primers were synthesized to construct the eukaryotic expressional vector, which included SfiI and EcoRI enzyme cleaving site, 6 x His and stop code TGA sequences. scFv(2F9) gene was amplified through splicing by overlap extension (SOE) using the high fidelity Taq polymerase. Positive recombinants (pSectag2A/scFv(2F9)) were identified through enzyme cleaving and sequenced before expression and were transformed into Chinese hamster ovary (CHO) cells for expression. Western-Blot and flow cytometry (FCM) were carried out to determine the relative molecular mass (Mr) and binding activity of scFv(2F9).RESULTS:The cloned scFv(2F9) gene was identified to be functional by sequencing and expressing. The interested protein could be detected in the culture supernatant of transformed CHO cells with an Mr of 31 000. The blocking test showed that the positive cell percentages, the mean fluorescence intensity (MFI) and the peak of channel (peak Ch) were reduced by 90.02%, 63.30% and 63.38%, respectively after blocking with scFv(2F9), while those were 4.55%, 10.09% and 5.02% after blockage using the supernatant from the CHO cells transfected with blanked vector pSectag2A.CONCLUSIONS:The scFv(2F9) against human CD14 antigen was successfully expressed in eukaryotic cells and showed a high biological activity, which may be useful for the further studies on its humanized antibodies.

Preparation and characteristic identification of monoclonal antibodies directed against sulfamethazine

Preparation and identification of monoclonal antibody against sulfonamides,sulfamerazine and sulfamethazine

Preparation and Characterization of Monoclonal Antibodies to Penicillin

Preparation of Monoclonal Antibody Against Chloramphenicol and Establishment of Direct Competitive ELISA for Determination of Chloramphenicol

Preparation and Characterization of Anti-Sulphamethoxazole (smx) Monoclonal Antibody

PREPARATION AND IMMUNOLOGICAL TRAIT OF MONOCLONAL ANTIBODY FOR SULFADIMETHOXINE

GENERATION AND IMMUNOLOGICAL TRAIT OF MONOCLONAL ANTIBODY FOR STREPTOMYCIN

Study on the monoclonal antibody to chlorpyrifos.

Synthesis and Identification of Sulfaquinoxaline Antificial Antigen

Preparation and Idenfication of Artificial Antigen of Streptomycin

Synthesis and Identification of the Sulfadimethoxine College Artificial Antigen

Preparation of the Polyclonal Antibodies against Sulfadiazine

Study on Preparation of Complete Antigen of Sulfamonomethoxine

Preparation and Identification of Amoxicillin Artificial Antigen by EDC Method

Development of A New Rabbit Monoclonal Antibody and Its Based Competitive Indirect Enzyme-Linked Immunosorbent Assay for Rapid Detection of Sulfonamides

Developments of the Monoclonal Antibodies Against Sulfamethoxazole and Immune Colloidal Gold-labeled Strip for Rapid Detection of Sulfamethoxazole

ESTABLISHMENT OF HYBRIDOMA CELL LINES SECRETING ANTI-CIMATEROL MONOCLONAL ANTIBODY AND PREPARATION,IDENTIFICATION OF THEIR IMMUNOLOGICAL PROPERTIES

[Eukaryotic Expression and Determination of ZCH-7-2F9 Single Chain Antibody Against Human CD14].

Synthesis and Characterization of Artifical Antigen of Olaquindox

Preparation and Identification of the Monoclonal Antibody Against Chlorothalonil

Preparation and the Specificity of Monoclonal Antibody against Saxitoxin